Joshua M DeMott Selected Research

Diltiazem (Cardizem)

1/2021	Evaluation of the blood pressure effects of diltiazem versus metoprolol in the acute treatment of atrial fibrillation with rapid ventricular rate.
1/2019	Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction.
1/2018	The authors respond "Metoprolol vs. diltiazem in the acute management of atrial fibrillation in patients with heart failure with reduced ejection fraction".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joshua M DeMott Research Topics

Disease

5	Critical Illness (Critically Ill) 12/2022 - 01/2020
3	Chronic Renal Insufficiency 01/2022 - 06/2019
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2021
3	Atrial Fibrillation 01/2021 - 01/2018
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 06/2019
2	Hemorrhage 02/2020 - 01/2019
2	Heart Failure 01/2019 - 01/2018
1	COVID-19 12/2022
1	Drug Hypersensitivity (Drug Allergy) 12/2022
1	Thrombocytopenia (Thrombopenia) 02/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Ischemic Stroke 12/2021
1	Hypertension (High Blood Pressure) 12/2021
1	Hypercalcemia (Milk Alkali Syndrome) 01/2021
1	Hypocalcemia 01/2021
1	Neoplasms (Cancer) 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2020
1	Hyperkalemia 06/2019
1	Abscess 01/2019
1	Epistaxis (Nosebleed) 01/2019
1	Vomiting 01/2019
1	Foreign Bodies (Foreign Body) 01/2019
1	Septic Shock (Toxic Shock Syndrome) 01/2018
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

3	Diltiazem (Cardizem)FDA LinkGeneric 01/2021 - 01/2018
3	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2021 - 01/2018
2	Vancomycin FDA LinkGeneric 12/2021 - 01/2021
2	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
1	Pharmaceutical PreparationsIBA 12/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2021
1	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 12/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	CalciumIBA 01/2021
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2021
1	Dexmedetomidine FDA Link 01/2021
1	Linezolid (Zyvox)FDA Link 01/2021
1	Levetiracetam (Keppra)FDA LinkGeneric 10/2020
1	Phenytoin (Dilantin)FDA LinkGeneric 10/2020
1	Vitamin K FDA Link 02/2020
1	Warfarin (Coumadin)FDA LinkGeneric 02/2020
1	Prothrombin (Factor II)IBA 02/2020
1	prothrombin complex concentrates (PPSB)IBA 02/2020
1	Cefepime (Maxipime)FDA LinkGeneric 01/2020
1	CreatinineIBA 01/2020
1	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 06/2019
1	PotassiumIBA 06/2019
1	Glucagon (Glukagon)FDA Link 01/2019
1	Tranexamic Acid (AMCA)FDA Link 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018

Therapy/Procedure

7	Therapeutics 12/2022 - 01/2018
2	Length of Stay 02/2022 - 01/2021
2	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2022 - 06/2019
1	Drug Therapy (Chemotherapy) 12/2022
1	Advanced Cardiac Life Support (Life Support, Advanced Cardiac) 12/2022
1	Critical Care (Surgical Intensive Care) 12/2022
1	Continuous Renal Replacement Therapy 02/2022
1	Intermittent Renal Replacement Therapy 02/2022
1	Duration of Therapy 01/2021